374 related items for PubMed ID: 26648497
1. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure.
Moura LR, Franco MF, Kirsztajn GM.
J Bras Nefrol; 2015; 37(4):475-80. PubMed ID: 26648497
[Abstract] [Full Text] [Related]
2. Therapeutic Response and Long-Term Renal Outcomes in Childhood Idiopathic Steroid-Resistant Nephrotic Syndrome: A Single-Center Study.
Jung J, Lee JH, Park YS.
Nephron; 2022; 146(4):327-334. PubMed ID: 34929692
[Abstract] [Full Text] [Related]
3. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D.
Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
[Abstract] [Full Text] [Related]
4. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[Abstract] [Full Text] [Related]
5. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA.
Pediatr Nephrol; 2018 Oct; 33(10):1773-1780. PubMed ID: 29982878
[Abstract] [Full Text] [Related]
6. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[Abstract] [Full Text] [Related]
7. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[Abstract] [Full Text] [Related]
8. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
[Abstract] [Full Text] [Related]
9. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP, Shatat IF, Supe K, Du Z, Kaskel FJ.
Am J Nephrol; 2008 Jun; 28(1):83-90. PubMed ID: 17914249
[Abstract] [Full Text] [Related]
10. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
Park CW, Song HC, Shin YS, Ahn SJ, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK.
Nephron; 1998 Jun; 79(1):44-9. PubMed ID: 9609461
[Abstract] [Full Text] [Related]
11. [Minimal change disease and focal segmental glomerulosclerosis].
Müller-Deile J, Schenk H, Schiffer M.
Internist (Berl); 2019 May; 60(5):450-457. PubMed ID: 30887070
[Abstract] [Full Text] [Related]
12. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
Chehade H, Parvex P, Poncet A, Werner D, Mosig D, Cachat F, Girardin E.
Pediatr Nephrol; 2013 Dec; 28(12):2299-306. PubMed ID: 23949592
[Abstract] [Full Text] [Related]
13. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
Tejani A, Phadke K, Nicastri A, Adamson O, Chen CK, Trachtman H, Tejani C.
Nephron; 1985 Dec; 41(2):170-3. PubMed ID: 4047274
[Abstract] [Full Text] [Related]
14. A prospective study of collapsing focal segmental glomerulosclerosis.
Raja R, Nada R, Yadav AK, Kumar A, Goyal A, Kumar V, Rathi M, Kohli HS, Gupta KL, Sakhuja V, Jha V.
Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
[Abstract] [Full Text] [Related]
15. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Tsukamoto T, Uchida S, Tsuruya K, Shoji T, Hayashi H, Akai Y, Fukunaga M, Konta T, Nishio S, Goto S, Tamai H, Nagai K, Katafuchi R, Masutani K, Wada T, Nishino T, Shirasaki A, Sobajima H, Nitta K, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Mizutani M, Akahori T, Naruse T, Hiramatsu T, Morozumi K, Mimura T, Saka Y, Ishimura E, Hasegawa H, Ichikawa D, Shigematsu T, Sato H, Narita I, Isaka Y, Japan Nephrotic Syndrome Cohort Study investigators.
J Nephrol; 2022 May; 35(4):1135-1144. PubMed ID: 35366214
[Abstract] [Full Text] [Related]
16. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
Meyrier A, Noël LH, Auriche P, Callard P.
Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258
[Abstract] [Full Text] [Related]
17. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
Hansrivijit P, Cheungpasitporn W, Thongprayoon C, Ghahramani N.
BMC Nephrol; 2020 Apr 15; 21(1):134. PubMed ID: 32293308
[Abstract] [Full Text] [Related]
18. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
Watanabe Y, Fujinaga S, Endo A, Endo S, Nakagawa M, Sakuraya K.
Pediatr Nephrol; 2020 Dec 15; 35(12):2377-2381. PubMed ID: 32964318
[Abstract] [Full Text] [Related]
19. Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
Mason PD.
J R Coll Physicians Lond; 1997 Dec 15; 31(2):137-41. PubMed ID: 9131509
[No Abstract] [Full Text] [Related]
20. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
Tune BM, Mendoza SA.
J Am Soc Nephrol; 1997 May 15; 8(5):824-32. PubMed ID: 9176855
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
